# reload+after+2024-01-20 14:48:04.398138
address1§2200 Powell Street
address2§Suite 310
city§EmeryVille
state§CA
zip§94608
country§United States
phone§510 204 7200
website§https://www.xoma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.
fullTimeEmployees§12
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Thomas M. Burns', 'age': 49, 'title': 'Senior VP of Finance & CFO', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 538448, 'exercisedValue': 0, 'unexercisedValue': 2102865}, {'maxAge': 1, 'name': 'Mr. Owen P. Hughes Jr.', 'age': 48, 'title': 'Executive Chairman & Interim CEO', 'yearBorn': 1975, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Brad  Sitko', 'title': 'Chief Investment Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§5
compensationRisk§7
shareHolderRightsRisk§2
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.504
priceToSalesTrailing12Months§54.457016
currency§USD
dateShortInterest§1702598400
forwardEps§-1.19
pegRatio§-0.54
exchange§NGM
quoteType§EQUITY
shortName§XOMA Corporation
longName§XOMA Corporation
firstTradeDateEpochUtc§518448600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a0e537e9-6238-305f-a250-adb19444e5ee
gmtOffSetMilliseconds§-18000000
targetHighPrice§74.0
targetLowPrice§74.0
targetMeanPrice§74.0
targetMedianPrice§74.0
recommendationMean§2.5
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§3.264
grossMargins§0.96690005
ebitdaMargins§0.0
trailingPegRatio§None
